scholarly journals Features of treatment of cervical dystonia associated with head tremor with botulinum toxin type A drugs under electro myographic control

2016 ◽  
Vol 23 (4) ◽  
pp. 65-69
Author(s):  
A. N. Korenko ◽  
A. A. Timofeeva ◽  
A. A. Skoromets ◽  
A. V. Tishkov
Keyword(s):  
Botulinum Toxin ◽  
Cervical Dystonia ◽  
Botulinum Toxin Type A ◽  
Type A ◽  
Botulinum Toxin Type ◽  
Head Tremor

scholarly journals The course of cervical dystonia with head tremor during botulinum toxin type A treatment

2017 ◽  
Vol 9 (4) ◽  
pp. 26-30
Author(s):  
A. N. Korenko ◽  
A. A. Skoromets ◽  
A. A. Timofeeva ◽  
A. V. Tishkov
Keyword(s):  
Botulinum Toxin ◽  
Cervical Dystonia ◽  
Botulinum Toxin Type A ◽  
Type A ◽  
Botulinum Toxin Type ◽  
Head Tremor

scholarly journals Botulinum toxin type A versus anticholinergics for cervical dystonia

2005 ◽  
Author(s):  
João Costa ◽  
Cláudia C Espírito-Santo ◽  
Ana A Borges ◽  
Peter Moore ◽  
Joaquim Ferreira ◽  
...  
Keyword(s):  
Botulinum Toxin ◽  
Cervical Dystonia ◽  
Botulinum Toxin Type A ◽  
Type A ◽  
Botulinum Toxin Type

scholarly journals Botulinum toxin type A therapy for cervical dystonia

2001 ◽  
Author(s):  
J Costa ◽  
JJ Ferreira ◽  
A Borges ◽  
C Espírito-Santo ◽  
M Coelho ◽  
...  
Keyword(s):  
Botulinum Toxin ◽  
Cervical Dystonia ◽  
Botulinum Toxin Type A ◽  
Type A ◽  
Botulinum Toxin Type

scholarly journals Treatment of cervical dystonia with botulinum toxin in a patient with myasthenia gravis

1999 ◽  
Vol 57 (3A) ◽  
pp. 683-685 ◽  
Author(s):  
MARCIA RUBIA R. GONÇALVES ◽  
EGBERTO R. BARBOSA ◽  
ANTONIO A. ZAMBON ◽  
PAULO E. MARCHIORI
Keyword(s):  
Botulinum Toxin ◽  
Myasthenia Gravis ◽  
Cervical Dystonia ◽  
Neuromuscular Transmission ◽  
Botulinum Toxin Type A ◽  
Type A ◽  
Botulinum Toxin Type ◽  
Rare Combination

We report the case of a 49-year-old woman who has the rare combination of myasthenia gravis and cervical dystonia. She was treated with botulinum toxin type A with good response and no evidence of deterioration of the myasthenic symptoms. We therefore conclude that it is possible to use botulinum toxin in the presence of defective neuromuscular transmission.

Factors influencing secondary non-response to botulinum toxin type A injections in cervical dystonia

2015 ◽  
Vol 21 (2) ◽  
pp. 111-115 ◽  
Author(s):  
Joaquim J. Ferreira ◽  
Carlo Colosimo ◽  
Roongroj Bhidayasiri ◽  
Maria Jose Marti ◽  
Pascal Maisonobe ◽  
...  
Keyword(s):  
Botulinum Toxin ◽  
Cervical Dystonia ◽  
Botulinum Toxin Type A ◽  
Type A ◽  
Botulinum Toxin Type ◽  
Factors Influencing
Sign in / Sign up

Export Citation Format

Share Document